iRhythm Technologies

General Information
Business:

We are a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. Our goal is to be the leading provider of first-line ambulatory electrocardiogram, or ECG, monitoring for patients at risk for arrhythmias. We have created a unique platform, called the ZIO Service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for up to 14 days, called the ZIO Patch, with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information.

Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees: 356
Founded: 2014
Contact Information
Address 650 Townsend Street, Suite 500, San Francisco, CA 94103, US
Phone Number (415) 632-5700
Web Address https://www.iRhythmTech.com
View Prospectus: iRhythm Technologies
Financial Information
Market Cap $359.1mil
Revenues $48.8 mil (last 12 months)
Net Income $-24.0 mil (last 12 months)
IPO Profile
Symbol IRTC
Exchange NASDAQ
Shares (millions): 6.3
Price range $17.00 - $17.00
Est. $ Volume $107.0 mil
Manager / Joint Managers J.P. Morgan/ Morgan Stanley
CO-Managers Canaccord Genuity/ BTIG
Expected To Trade: 10/20/2016
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change